Search for: "BIOGEN INC."
Results 1 - 20
of 259
Sorted by Relevance
|
Sort by Date
29 Sep 2020, 9:50 pm
The Federal Circuit recently reinforced the primacy of these rubrics in Biogen MA, Inc. v. [read post]
19 Nov 2018, 9:49 pm
Biogen MA, Inc., the Federal Circuit affirmed a decision by the U.S. [read post]
10 Oct 2012, 11:00 pm
On Wednesday, October 10, 2012, our firm defeated defendant Biogen Idec, Inc's motion to continue trial. [read post]
19 May 2015, 9:59 pm
§ 146 pursuant to changes in the statute provided by the Leahy-Smith America Invents Act, in Biogen MA, Inc. v. [read post]
17 Apr 2013, 9:59 pm
By Donald Zuhn -- Yesterday, in Biogen Idec, Inc. v. [read post]
31 Aug 2011, 9:59 pm
Biogen IDEC. [read post]
17 Oct 2022, 12:00 pm
Biogen Inc. and Eisai Co. have partnered together on experimental drug, lecanemab, which they say significantly slowed symptoms of Alzheimer’s. [read post]
30 Sep 2020, 6:33 am
Court of Appeals for the Federal Circuit issued a precedential decision in Biogen MA, Inc. v. [read post]
17 Mar 2022, 9:06 pm
Mylan Pharmaceuticals Inc. [read post]
8 Sep 2011, 9:59 pm
Biogen IDEC is a separate explication of "additional views" by Chief Judge Rader (at right) joined by Judge Newman. [read post]
6 Sep 2011, 9:55 pm
Noonan -- The Federal Circuit majority decision in Classen Immunotherapies, Inc. v. [read post]
30 Dec 2021, 8:07 am
Mylan Pharmaceuticals Inc., November 30, 2021, Reyna, J.). [read post]
29 Jan 2008, 4:26 am
Icahn renewed his efforts Monday to push Biogen Idec Inc. to find a buyer, saying last year’s failed effort to sell the Cambridge, [...] [read post]
25 Jul 2022, 9:21 am
Biogen Inc. [read post]
29 Apr 2013, 12:23 pm
By Jason Rantanen Biogen Idec, Inc. v. [read post]
24 Jul 2022, 9:48 pm
On July 20, Biogen, Inc, an international pharmaceutical company, agreed to pay $900 million to resolve a False Claims Act qui tam whistleblower suit. [read post]
28 Sep 2022, 5:19 pm
According to DOJ’s press release: Pharmaceutical company Biogen Inc. [read post]
8 Jan 2023, 1:00 pm
Food and Drug Administration gave accelerated approval to the Alzheimer’s drug lecanemab, developed by Eisai Co. and Biogen Inc. [read post]
16 Apr 2013, 8:30 pm
The STRATEGY in the Biogen case is similar to what was employed by Butamax in the Gevo case:Biogen Idec Inc. and Genentech, Inc. [read post]
30 Sep 2020, 6:33 am
Court of Appeals for the Federal Circuit issued a precedential decision in Biogen MA, Inc. v. [read post]
